PALM2AKAP2 and colorectal carcinoma: Finally, PALM2 has been reported to be upregulated in responder CRC tumors to MS-275, a selective histone deacetylase inhibitor that disturbs cell adhesion, response to extracellular stimuli and transcription cellular processes [31].